Quick Answer
SRx Health Solutions, Inc. reported Diluted EPS of $2.13 per share (loss) for fiscal year 2025.
SRx Health Solutions, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.13 | -2030.0% |
| 2024 | -$0.10 | +94.9% |
| 2024 | -$1.95 | +94.0% |
| 2023 | -$32.29 | +45.2% |
| 2022 | -$58.93 | -42192.9% |
| 2021 | $0.14 | +101.9% |
| 2020 | -$7.26 | -36200.0% |
| 2017 | -$0.02 | -100.0% |
| 2016 | -$0.01 | — |
| 2015 | $0.00 | — |
| 2014 | $0.00 | +100.0% |
| 2013 | -$1.56 | -500.0% |
| 2012 | -$0.26 | +61.8% |
| 2011 | -$0.68 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.26 | -52.9% | +64.9% |
| June 30, 2025 | -$0.74 | -428.6% | -100.0% |
| March 31, 2025 | -$0.37 | +89.7% | -117.6% |
| December 31, 2024 | -$0.17 | — | -123.3% |
| September 30, 2024 | $0.73 | +131.7% | +621.4% |
| June 30, 2024 | -$0.14 | +96.7% | +96.1% |
| March 31, 2024 | -$3.60 | +28.4% | -56.5% |
| September 30, 2023 | -$2.30 | -945.5% | +46.1% |
- SRx Health Solutions, Inc. showed a decrease of -2030.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2011–2025 period, SRx Health Solutions, Inc.’s diluted eps has declined by 213.2% (from $0.68 per share (loss) to $2.13 per share (loss)).
- The most recent figure is from SRx Health Solutions, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 5, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: